Differential and special properties of the major human UGT1-encoded gastrointestinal UDP-glucuronosyltransferases enhance potential to control chemical uptake

被引:71
作者
Basu, NK [1 ]
Ciotti, M [1 ]
Hwang, MS [1 ]
Kole, L [1 ]
Mitra, PS [1 ]
Cho, JW [1 ]
Owens, IS [1 ]
机构
[1] NICHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.M306439200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
UDP- glucuronosyltransferase (UGT) isozymes detoxify metabolites, drugs, toxins, and environmental chemicals via conjugation to glucuronic acid. Based on the extended UGT1 locus combined with Northern blot analysis and in situ hybridization, we determined the distribution of UGT1A1 and UGT1A7 through UGT1A10 mRNAs and found them for the first time segmentally distributed in the mucosal epithelia layer of the gastrointestinal tract. Biochemically, recombinant isozymes exhibited pH optima of 5.5, 6.4, 7.6, 8.5, and/or a broad pH range, and activities were found to be unaffected or progressively inhibited by increasing substrate concentrations after attaining V-max for certain chemicals. Under different optimal conditions, all exhibited wide substrate selections for dietary and environmentally associated chemicals. Evidence also suggests tandem effects of isozymes in the time for completion of reactions when comparing short- and long-term incubations. Moreover, treatment of colon cells with certain diet-associated constituents, curcumin and nordihydroguaiaretic acid, reversibly targets UGTs causing inhibition without affecting protein levels; there is no direct inhibition of control UGT using curcumin as substrate in the in vitro assay. In summary, we demonstrate that UGTs are located in gastrointestinal mucosa, have vast overlapping activities under differential optimal conditions, and exhibit marked sensitivity to certain dietary substrates/constituents, representing a first comprehensive study of critical properties concerning glucuronidating isozymes in alimentary tissues. Additionally, the highly dynamic, complex, and variable properties necessarily impact absorption of ingested chemicals and therapeutic drugs.
引用
收藏
页码:1429 / 1441
页数:13
相关论文
共 34 条
[1]   Evidence for phosphorylation requirement for human bilirubin UDP-glucuronosyltransferase (UGT1A1) activity [J].
Basu, NK ;
Kole, L ;
Owens, IS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 303 (01) :98-104
[2]   PARACETAMOL GLUCURONIDATION BY RECOMBINANT RAT AND HUMAN PHENOL UDP-GLUCURONOSYLTRANSFERASES [J].
BOCK, KW ;
FORSTER, A ;
GSCHAIDMEIER, H ;
BRUCK, M ;
MUNZEL, P ;
SCHARECK, W ;
FOURNELGIGLEUX, S ;
BURCHELL, B .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (09) :1809-1814
[3]   Tissue-specific regulation of canine intestinal and hepatic phenol and morphine UDP-glucuronosyltransferases by β-naphthoflavone in comparison with humans [J].
Bock, KW ;
Bock-Hennig, BS ;
Münzel, PA ;
Brandenburg, JO ;
Köhle, CT ;
Soars, MG ;
Riley, RJ ;
Burchell, B ;
von Richter, O ;
Eichelbaum, MF ;
Swedmark, S ;
Orzechowski, A .
BIOCHEMICAL PHARMACOLOGY, 2002, 63 (09) :1683-1690
[4]   A REVIEW OF THE GENETIC-EFFECTS OF NATURALLY-OCCURRING FLAVONOIDS, ANTHRAQUINONES AND RELATED-COMPOUNDS [J].
BROWN, JP .
MUTATION RESEARCH, 1980, 75 (03) :243-277
[5]   Cloning and expression of human UDP-glucuronosyltransferase (UGT) 1A8 [J].
Cheng, ZQ ;
Radominska-Pandya, A ;
Tephly, TR .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 356 (02) :301-305
[6]   Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications [J].
Ciotti, M ;
Marrone, A ;
Potter, C ;
Owens, IS .
PHARMACOGENETICS, 1997, 7 (06) :485-495
[7]   Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus [J].
Ciotti, M ;
Basu, N ;
Brangi, M ;
Owens, IS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 260 (01) :199-202
[8]   Evidence for overlapping active sites for 17 alpha-ethynlestradiol and bilirubin in the human major bilirubin UDPglucuronosyltransferase [J].
Ciotti, M ;
Owens, IS .
BIOCHEMISTRY, 1996, 35 (31) :10119-10124
[9]   ALTERED CODING FOR A STRICTLY CONSERVED DI-GLYCINE IN THE MAJOR BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE OF A CRIGLER-NAJJAR TYPE-I PATIENT [J].
CIOTTI, M ;
YEATMAN, MT ;
SOKOL, RJ ;
OWENS, IS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (07) :3284-3291
[10]  
Court MH, 2001, J PHARMACOL EXP THER, V299, P998